Abstract
Long-term oral treatment of patients with acute coronary syndromes and type 2 diabetes mellitus with β-adrenoblockers and angiotensin-converting enzyme inhibitors is associated with positive, though ambiguous changes in the left-ventricular structure and function. These changes should be the reason for choosing optimal therapy ensuring better prognosis in this patient population.
Similar content being viewed by others
REFERENCES
M. E. Bertrand M. L. Simoons K. A. Fox et al. (2002) Eur. Heart J. 23 1809–1840
Z. T. Bloomgarden (2003) Diabetes Care 26 230–237
P. Dubach J. Myers P. Bonetti et al. (2002) Am. Heart J. 143 676–683
A. Hjalmarson (2000) Basic Res. Cardiol. 95 IssueIDSuppl. 1 141–145
K. J. Mukamal R. W. Nesto M. C. Cohen et al. (2001) Diabetes Care 24 1422–1427 Occurrence Handle1:STN:280:DC%2BD3MvktVOltw%3D%3D Occurrence Handle11473080
H. E. Resnick B. V. Howard (2002) Annu. Rev. Med. 53 245–267
InstitutionalAuthorNameStandards of Medical Care for Patients with Diabetes Mellitus (2003) Diabetes Care 26 S33–S50
F. Werf ParticleVan der D. Ardissino A. Betriu et al. (2003) Eur. Heart J. 24 28–66
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 138, No. 9, pp. 341–344, September, 2004
Rights and permissions
About this article
Cite this article
Ivanova, L.A., Kanorskii, S.G., Rostovtseva, O.N. et al. Treatment of acute coronary syndromes in patients with type 2 diabetes mellitus with β-adrenoblockers and angiotensin-converting enzyme inhibitors: cardiohemodynamic effects and impact for prognosis. Bull Exp Biol Med 138, 301–304 (2004). https://doi.org/10.1007/s10517-005-0026-7
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-005-0026-7